logo
Select company
Select metric
11.13%Capital Expenditures Margin
VS
Market
21
Sector
19
Industry
33
History
88
$ 1.61Close
$ 1.24 - $ 11.05 52-Week Range
Ticker Information

Ticker

SXTP

Company Name

60 DEGREES PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

60 DEGREES PHARMACEUTICALS INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SXTP - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 94.61K11.13%$ 850.38K
3/31/2025$ 160.5K22.35%$ 718.26K
12/31/2024$ 155.74K22.86%$ 681.35K
9/30/2024$ 220.2K47.6%$ 462.61K
6/30/2024$ 200.48K45.43%$ 441.25K
3/31/2024$ 95.04K25.13%$ 378.2K
12/31/2023$ 97.61K38.49%$ 253.57K
12/31/2022$ 33.06K41.94%$ 78.84K
12/31/2021$ 35.39K0.64%$ 5.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • 60 DEGREES PHARMACEUTICALS INC's latest trailing twelve months (TTM) CapEx % stands at 0.64%.
  • Over the past 5 years, 60 DEGREES PHARMACEUTICALS INC's average CapEx % has been 28.4%.
  • The median CapEx % for 60 DEGREES PHARMACEUTICALS INC during this period was 25.13%
  • 60 DEGREES PHARMACEUTICALS INC reached its highest CapEx % over the past 5 years at 47.6%.
  • The lowest CapEx % recorded by 60 DEGREES PHARMACEUTICALS INC in the same timeframe 0.64%

60 DEGREES PHARMACEUTICALS INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
SPRB : SPRUCE BIOSCIENCES INC -ONCO : ONCONETIX INC 0.47%APRE : APREA THERAPEUTICS INC -VIVS : VIVOSIM LABS INC -PTIX : PROTAGENIC THERAPEUTICS INC -SLXN : SILEXION THERAPEUTICS CORP -TCRT : ALAUNOS THERAPEUTICS INC -VYNE : VYNE THERAPEUTICS INC 24.58%KTTA : PASITHEA THERAPEUTICS CORP -ADTX : ADITXT INC -

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for 60 DEGREES PHARMACEUTICALS INC is calculated as follows: CapEx [ $ 35.39K ] / Revenues [ $ 5.5M ]
(=) CapEx % [ 0.64% ]

SXTP - Capital Expenditures Margin, Last 5 years

0.64%

Minimum

Dec 31, 2021

47.6%

Maximum

Sep 30, 2024

28.4%

Average

25.13%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.47% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.02%
average3.47%
median2.43%
std3.27%